[Prognosis and Related Factors of Patients with Pathological Complete Response after Neoadjuvant Therapy for Gastric Cancer].
Tong-Bo Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dongbing Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingtai Chen(Shanghai Jiao Tong University), Chunguang Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Hong Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Aiping Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaojie Zhang(Shanghai Jiao Tong University), Jing Jin(Chinese Academy of Medical Sciences & Peking Union Medical College), Chongyuan Sun(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 3
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer
|Theranostics|2022|154
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
|Nature Medicine|2024|116
Long-Term Treatment with Lithium Alleviates Memory Deficits and Reduces Amyloid-β Production in an Aged Alzheimer's Disease Transgenic Mouse Model
|Journal of Alzheimer s Disease|2011|114